Caroline Wigerup (Former)
11 – 20 of 30
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
p27(Kip1) is a predictive factor for tamoxifen treatment response but not a prognostic marker in premenopausal breast cancer patients.
(
- Contribution to journal › Article
- 2009
-
Mark
Phosphorylation of ERα and HIF-1α in breast cancer with focus on tamoxifen response and links to kinase activation
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Role of p27 in tamoxifen response in breast cancer cell lines
(
- Contribution to journal › Published meeting abstract
-
Mark
Estrogen Receptor-{alpha} Phosphorylation at Serine-118 and Tamoxifen Response in Breast Cancer.
(
- Contribution to journal › Article
-
Mark
Phosphorylation of the oestrogen receptor alpha at serine 305 and prediction of tamoxifen resistance in breast cancer.
(
- Contribution to journal › Article
-
Mark
Extranuclear Coactivator Signaling Confers Insensitivity to Tamoxifen.
(
- Contribution to journal › Article
- 2008
-
Mark
Oestrogen receptor beta immunohistochemistry: time to get it right? Authors' response
(
- Contribution to journal › Letter
-
Mark
Oestrogen receptors alpha and beta show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer.
(
- Contribution to journal › Article
- 2007
-
Mark
Hypoxia and breast cancer: prognostic and therapeutic implications
(
- Contribution to journal › Scientific review
- 2006
-
Mark
Breast cancer-amplified sequence 3, a target of metastasis-associated protein 1, contributes to tamoxifen resistance in premenopausal patients with breast cancer
(
- Contribution to journal › Article